{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:18:41Z","timestamp":1778627921403,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX002299"],"award-info":[{"award-number":["I01 BX002299"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI145108 -01"],"award-info":[{"award-number":["R01AI145108 -01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI116501"],"award-info":[{"award-number":["P01AI116501"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL166402"],"award-info":[{"award-number":["R01HL166402"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL128492"],"award-info":[{"award-number":["R01HL128492"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.athoracsur.2023.03.007","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T12:08:10Z","timestamp":1678709290000},"page":"1150-1158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Regadenoson Reduces Soluble Receptor for Advanced Glycation End-Products in Lung Recipients"],"prefix":"10.1016","volume":"116","author":[{"given":"Yunge","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urmil","family":"Dhru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezzat","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Al-Suqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Conaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Krupnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9921-0598","authenticated-orcid":false,"given":"Christine L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2023.03.007_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.healun.2012.08.004","article-title":"The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012","volume":"31","author":"Christie","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib2","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jtcvs.2005.01.022","article-title":"Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients","volume":"129","author":"Meyers","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib3","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.21037\/jtd.2017.09.09","article-title":"Pathophysiology and classification of primary graft dysfunction after lung transplantation","volume":"9","author":"Morrison","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.200608-1079OC","article-title":"Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome","volume":"175","author":"Daud","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib5","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1111\/ajt.12368","article-title":"Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury","volume":"13","author":"Sharma","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.imbio.2009.11.001","article-title":"HMGB1 activates nuclear factor-\u03baB signaling by RAGE and increases the production of TNF-\u03b1 in human umbilical vein endothelial cells","volume":"215","author":"Luan","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.jid.5700070","article-title":"The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha","volume":"126","author":"Lohwasser","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1164\/rccm.200901-0118OC","article-title":"Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction","volume":"180","author":"Christie","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/TP.0000000000001523","article-title":"Predicting primary graft dysfunction after lung transplantation: trying to catch it early","volume":"101","author":"Diamond","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.healun.2012.05.001","article-title":"A\u00a0panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation","volume":"31","author":"Shah","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/TP.0000000000001434","article-title":"Increased extravascular lung water and plasma biomarkers of acute lung injury precede oxygenation impairment in primary graft dysfunction after lung transplantation","volume":"101","author":"Pottecher","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.200509-1477OC","article-title":"Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury","volume":"173","author":"Uchida","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1600-6143.2009.02995.x","article-title":"Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation","volume":"10","author":"Pelaez","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib14","doi-asserted-by":"crossref","first-page":"35507","DOI":"10.1074\/jbc.M806948200","article-title":"Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases","volume":"283","author":"Zhang","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jss.2018.10.034","article-title":"Acidic preconditioning protects against ischemia-reperfusion lung injury via inhibiting the expression of matrix metalloproteinase 9","volume":"235","author":"Qu","year":"2019","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1164\/rccm.201506-1253OC","article-title":"NOX2 activation of natural killer T cells is blocked by the adenosine A2A receptor to inhibit lung ischemia-reperfusion injury","volume":"193","author":"Sharma","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib17","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jtcvs.2011.06.015","article-title":"Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model","volume":"142","author":"LaPar","year":"2011","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/bloodadvances.2017009613","article-title":"Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease","volume":"1","author":"Field","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.healun.2020.02.003","article-title":"Adenosine A2A receptor agonist (regadenoson) in human lung transplantation","volume":"39","author":"Lau","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.athoracsur.2023.03.007_bib20","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1016\/j.healun.2022.01.1063","article-title":"Regadenoson is safe and reduces systemic inflammation post lung transplantation","volume":"41","author":"Zhao","year":"2022","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.athoracsur.2011.04.065","article-title":"Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker","volume":"92","author":"LaPar","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib22","doi-asserted-by":"crossref","first-page":"L718","DOI":"10.1152\/ajplung.00227.2010","article-title":"Depletion of tissue plasminogen activator attenuates lung ischemia-reperfusion injury via inhibition of neutrophil extravasation","volume":"300","author":"Zhao","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820969340","article-title":"Induced pluripotent stem cells attenuate acute lung injury induced by ischemia reperfusion via suppressing the high mobility group box-1","volume":"18","author":"Li","year":"2020","journal-title":"Dose Response"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5301\/JBM.2011.8831","article-title":"MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer","volume":"26","author":"Reis","year":"2011","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.amjms.2017.12.013","article-title":"Chronic alcohol ingestion impairs rat alveolar macrophage phagocytosis via disruption of RAGE signaling","volume":"355","author":"Staitieh","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib26","first-page":"1147","article-title":"Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung","volume":"44","author":"Fehrenbach","year":"1998","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101958","article-title":"The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes","volume":"42","author":"Erusalimsky","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib28","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A\u00a0soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib29","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1097\/TP.0000000000000830","article-title":"Ex\u00a0vivo perfusion with adenosine A2A receptor agonist enhances rehabilitation of murine donor lungs after circulatory death","volume":"99","author":"Stone","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib30","first-page":"2507","article-title":"Soluble receptor for advanced glycation end-products enhanced the production of IFN-\u03b3 through the NF-\u03baB pathway in macrophages recruited by ischemia\/reperfusion","volume":"43","author":"Zhang","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib31","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.4049\/jimmunol.0903398","article-title":"sRAGE induces human monocyte survival and differentiation","volume":"185","author":"Wang","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib32","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1002\/art.22217","article-title":"Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1","volume":"54","author":"Pullerits","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/BJ20050888","article-title":"Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction","volume":"391","author":"Murphree","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib34","article-title":"NF-\u03baB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/13543784.2012.681043","article-title":"Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9","volume":"21","author":"Kowluru","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.matbio.2012.07.001","article-title":"The stimulation of adenosine 2A receptor reduces inflammatory response in mouse articular chondrocytes treated with hyaluronan oligosaccharides","volume":"31","author":"Campo","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.athoracsur.2023.03.007_bib37","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1096\/fj.201701553RR","article-title":"JNK and ATF4 as two important platforms for tumor necrosis factor-\u03b1-stimulated shedding of receptor for advanced glycation end products","volume":"33","author":"Miyoshi","year":"2019","journal-title":"FASEB J"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497523002783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497523002783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:56:53Z","timestamp":1778626613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497523002783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0003497523002783"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2023.03.007","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regadenoson Reduces Soluble Receptor for Advanced Glycation End-Products in Lung Recipients","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2023.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The Society of Thoracic Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}